Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13

Indacaterol/glycopyrronium reduces the risk of clinically important deterioration after direct switch from baseline therapies in patients with moderate COPD: a post hoc analysis of the CRYSTAL study

Total article views   Abstract views HTML views PDF downloads Totals
6,258 Dovepress* 4,979 706+ 1,684 5,685
PubMed Central* 0 573 311 573
Totals 4,979 1,279 1,995 6,258
*Since 16 April 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
29 0 0 0 14 15

View citations on PubMed Central and Google Scholar